Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of Clinical Equivalence Between Two Lubiprostone Products

ClinicalTrials.gov ID: NCT01372423

Public ClinicalTrials.gov record NCT01372423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Evaluate the Clinical Equivalence of Lubiprostone 24 Mcg Capsules (Anchen Pharmaceuticals, Inc.) With AMITIZA® (Lubiprostone) 24 Mcg Capsules (Sucampo Pharmaceuticals, Inc.) in the Treatment of Chronic Idiopathic Constipation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the clinical equivalence and safety of the Test formulation of lubiprostone 24 mcg capsules compared to the marketed formulation AMITIZA® (lubiprostone) 24 mcg capsules (Sucampo Pharmaceuticals, Inc.) in patients with confirmed chronic idiopathic constipation.

Study identification

NCT ID
NCT01372423
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Anchen Pharmaceuticals, Inc
Industry
Enrollment
808 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2011 (Type not available)
Primary completion
Jun 2012 (Actual)
Completion
Jun 2012 (Actual)
Last update posted
Jul 12, 2012

2011 – 2012

United States locations

U.S. sites
79
U.S. states
27
U.S. cities
79
Facility City State ZIP Site status
Novum Investigator Site Dothan Alabama — —
Novum Investigator Site Huntsville Alabama — —
Novum Investigator Site Mobile Alabama — —
Novum Investigator Site Chandler Arizona — —
Novum Investigator Site Gilbert Arizona — —
Novum Investigator Site Mesa Arizona — —
Novum Investigator Site Phoenix Arizona — —
Novum Investigator Site Phoeniz Arizona — —
Novum Investigator Site Hot Springs Arkansas — —
Novum Investigator Site Little Rock Arkansas — —
Novum Investigator Site Mountain Home Arkansas — —
Novum Investigator Site Sherwood Arkansas — —
Novum Investigator Site Buena Park California — —
Novum Investigator Site Fresno California — —
Novum Investigator Site Garden Grove California — —
Novum Investigator Site La Palma California — —
Novum Investigator Site Long Beach California — —
Novum Investigator Site Sacremento California — —
Novum Investigator Site San Diego California — —
Novum Invesitgator Site San Ramon California — —
Novum Investigator Site Santa Ana California — —
Novum Investigator Site Westlake Village California — —
Novum Investigator Site Denver Colorado — —
Novum Investigator Site Wheat Ridge Colorado — —
Novum Investigator Site Adventura Florida — —
Novum Investigator Site Boyton Beach Florida — —
Novum Investigator Site Bradenton Florida — —
Novum Investigator Site Brookville Florida — —
Novum Investigator Site Clearwater Florida — —
Novum Investigator Site Deerfield Beach Florida — —
Novum Investigator Site Jupiter Florida — —
Novum Investigator Site Maimi Florida — —
Novum Investigator Site Miami Florida — —
Novum Investigator Site Niceville Florida — —
Novum Investigator Site Ormond Beach Florida — —
Novum Investigator Site Panama City Florida — —
Novum Investigator Site Port Orange Florida — —
Novum Investigator Site St. Petersburg Florida — —
Novum Investigator Site Tampa Florida — —
Novum Investigator Site West Palm Beach Florida — —
Novum Investigator Site Decauter Georgia — —
Novum Investigator Site Sandy Springs Georgia — —
Novum Investigator Site Stockbridge Georgia — —
Novum Investigator Site Lewiston Idaho — —
Novum Investigator Site Rockford Illinois — —
Novum Investigator Site Evansville Indiana — —
Novum Investigator Site Lexington Kentucky — —
Novum Investigator Site Shreveport Louisiana — —
Novum Invesitgator Site Hollywood Maryland — —
Novum Investigator Site Jackson Mississippi — —
Novum Investigator Site Mexico Missouri — —
Novum Investigator Site Washington Missouri — —
Novum Investigator Site Billings Montana — —
Novum Investigator Site Lincoln Nebraska — —
Novum Investigator Site Henderson Nevada — —
Novum Investigator Site Marlton New Jersey — —
Novum Investigator Site Newport News New Jersey — —
Novum Investigator Site Poughkeepsie New York — —
Novum Investigator Site Cary North Carolina — —
Novum Investigator Site Charlotte North Carolina — —
Novum Investigator Site High Point North Carolina — —
Novum Investigator Site Raleigh North Carolina — —
Novum Investigator Site Salisbury North Carolina — —
Novum Investigator Site Wilmington North Carolina — —
Novum Investigator Site Winstom-Salem North Carolina — —
Novum Investigator Site Beavercreek Ohio — —
Novum Investigator Site Centerville Ohio — —
Novum Investigator Site Sylvania Ohio — —
Novum Investigator Site Columbia South Carolina — —
Novum Investigator Site Chattanooga Tennessee — —
Novum Investigator Site Germantown Tennessee — —
Novum Investigator Site Hermitage Tennessee — —
Novum Investigator Site Houston Texas — —
Novum Investigator Site Longview Texas — —
Novum Investigator Site San Antonio Texas — —
Novum Investigator Site Sugarland Texas — —
Novum Investigator Site Charlottesville Virginia — —
Novum Investigator Site Virginia Beach Virginia — —
Novum Investigator Site Mountain Lake Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01372423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2012 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01372423 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →